Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that Globus Medical, Inc. made materially false and/or misleading statements and/or failed to disclose that: Globus issued a press release reporting its financial results for the first quarter of 2025 On May 8, 2025. Among other items, Globus reported non-GAAP earnings per share of $0.68, missing consensus estimates by $0.06, and revenue of $598.12 million, missing consensus estimates by $27.78 million and representing a 1.4% year-over-year decline. Globus’s President and Chief Executive Officer said that the Company’s “first quarter results were impacted by softer Enabling Technology deal closures, temporary integration related supply chain disruption, and timing of international distributor orders[.]” Following this news, Globus’s stock price fell over 22% on May 9, 2025.
In order to be eligible to join the GMED class action lawsuit, you must have incurred a loss on shares of Globus Medical, Inc. purchased during the class period listed above.
TOP
